Is England closing the international gap in cancer survival?

British Journal of Cancer

Volumn 113, Issue 5, 2015, Pages 848-860

  Walters, Sarah ^a   Benitez Majano, Sara ^a   Muller, Patrick ^a   Coleman, Michel P ^a   Allemani, Claudia ^a   Butler, John ^a,b   Peake, Mick ^c   Guren, Marianne Grønlie ^d,e   Glimelius, Bengt ^f   Bergström, Stefan ^g   Påhlman, Lars ^f   Rachet, Bernard ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b ROYAL MARSDEN HOSPITAL   (United Kingdom)

^c GLENFIELD HOSPITAL   (United Kingdom)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^g GÄVLE HOSPITAL   (Sweden)

Author keywords

cancer registries; cancer survival; international comparison; population based

Indexed keywords

ARTICLE; AUSTRALIA; BREAST CANCER; CANADA; CANCER CONTROL; CANCER DIAGNOSIS; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; COLON CANCER; DENMARK; DEVELOPED COUNTRY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; NET SURVIVAL; NORWAY; OVARY CANCER; PRIORITY JOURNAL; RECTUM CANCER; STOMACH CANCER; SWEDEN; UNITED KINGDOM; ADOLESCENT; ADULT; AGED; COMPARATIVE STUDY; EPIDEMIOLOGY; HEALTH CARE QUALITY; MIDDLE AGED; MORTALITY; NEOPLASM; TOTAL QUALITY MANAGEMENT; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DEVELOPED COUNTRIES; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY IMPROVEMENT; QUALITY INDICATORS, HEALTH CARE; YOUNG ADULT;

EID: 84940793383     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.265     Document Type: Article

References (86)

1. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A, Marcos-Gragera R, Stiller C, Azevedo ESG, Chen WQ, Ogunbiyi OJ, Rachet B, Soeberg MJ, You H, Matsuda T, Bielska-Lasota M, Storm H, Tucker TC, Coleman MP. The CONCORD Working Group (2015) Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 385(9972): 977-1010.
2. Bang YJ, Van Cutsem E, Feyereislova A, Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T, Aprile G, Kulikov E, Hill J, Lehle M, Ruschoff J, Kang YK, ToGA Trial Investigators (2010) Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 376(9742): 687-697.
3. Beckett P, Woolhouse I, Stanley R, Peake MD (2012) Exploring variations in lung cancer care across the UK - the 'story so far' for the National Lung Cancer Audit. Clin Med 12(1): 14-18.
4. Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Estève J (eds) (1995) Survival of Cancer Patients in Europe: The EUROCARE Study (IARC Scientific Publications No. 132). International Agency for Research on Cancer: Lyon, France.
5. Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL (2003) Surgeon volume and operative mortality in the United States. N Engl J Med 349(22): 2117-2127.
6. Blum TG, Rich A, Baldwin D, Beckett P, De Ruysscher D, Faivre-Finn C, Gaga M, Gamarra F, Grigoriu B, Hansen NC, Hubbard R, Huber RM, Jakobsen E, Jovanovic D, Konsoulova A, Kollmeier J, Massard G, McPhelim J, Meert AP, Milroy R, Paesmans M, Peake M, Putora PM, Scherpereel A, Schonfeld N, Sitter H, Skaug K, Spiro S, Strand TE, Taright S, Thomas M, van Schil PE, Vansteenkiste JF, Wiewrodt R, Sculier JP (2014) The European initiative for quality management in lung cancer care. Eur Respir J 43(5): 1254-1277.
7. Brenner H, Gefeller O (1996) An alternative approach to monitoring cancer patient survival. Cancer 78(9): 2004-2010.
8. Brenner H, Rachet B (2004) Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer 40(16): 2494-2501.
9. Butler J, Gildea C, Poole J, Meechan D, Nordin A (2015) Specialist surgery for ovarian cancer in England. Gynecol Oncol; e-pub ahead of print 31 March 2015; doi:10.1016/j.ygyno.2015.03.003.
10. Canadian Strategy for Cancer Control Governing Council (2006) The Canadian Strategy for Cancer Control: A Cancer Plan for Canada. CSCC Governing Council: Toronto, ON, Canada.
11. Cancer Care Ontario (2004) Ontario Cancer Plan 2005-2008. Cancer Care Ontario: Toronto, ON, Canada.
12. Cancer Care Ontario (2012) Lung Cancer Diagnosis Pathway. Cancer Care Ontario: Toronto, ON, Canada.
13. Cancer Institute New South Wales (2004) New South Wales Cancer Plan 2004-2006. Cancer Institute NSW: Sydney, NSW, Australia.
14. Cancer Research UK (2012) Cancer Services: Reverse, Pause or Progress? Cancer Research UK: London, UK.
15. Clerc-Urmès I, Grzebyk M, Hédelin G (2014) Net survival estimation with stns. Stata J 14: 87-102.
16. Coburn NG, Lourenco LG, Rossi SE, Gunraj N, Mahar AL, Helyer LK, Law C, Rabeneck L, Paszat L (2010) Management of gastric cancer in Ontario. J Surg Oncol 102(1): 54-63.
17. Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C, Nur U, Tracey E, Coory M, Hatcher J, McGahan CE, Turner D, Marrett L, Gjerstorff ML, Johannesen TB, Adolfsson J, Lambe M, Lawrence G, Meechan D, Morris EJ, Middleton R, Steward J, Richards MA, The ICBP Module 1 Working Group (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760): 127-138.
18. Corazziari I, Quinn M, Capocaccia R (2004) Standard cancer patient population for age standardising survival ratios. Eur J Cancer 40(15): 2307-2316.
19. Cromwell D, Palser T, van der Meulen JH, Hardwick R, Riley S, Greenaway K, Dean S (2010) National Oesophago-Gastric Cancer Audit 2010. The Royal College of Surgeons of England: London, UK.
20. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, Smith DB, Langley RE, Verma M, Weeden S, Chua YJ, Magic Trial Participants (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355(1): 11-20.
21. Dahlberg M, Påhlman L, Bergström R, Glimelius B (1998) Improved survival in patients with rectal cancer: a population-based register study. Br J Surg 85(4): 515-520.
22. Dalkey NC, Helmer O (1963) An experimental application of the Delphi method to the use of experts. Manage Sci 9(3): 458-467.
23. Danish National Board of Health (2000) The National Cancer Plan Summary. National Board of Health: Copenhagen, Denmark.
24. Dansk Lunge Cancer Gruppe (2014) Lungecancer visitation, diagnose & stadienddeling. Dansk Lunge Cancer Gruppe: Odense, Denmark.
25. Darling G, Dickie A, Malthaner R, Kennedy E, Tey R, Invasive Mediastinal Staging Expert Panel (2010) Invasive Mediastinal Staging of Non-small-cell Lung Cancer: A Clinical Practice Guideline. Cancer Care Ontario: Toronto, ON, Canada.
26. Department of Health (2000) The NHS Cancer Plan. Department of Health: London, UK.
27. Department of Health (2007) Cancer Reform Strategy. Department of Health: London, UK.
28. Department of Health (2011) Improving Outcomes: A Strategy for Cancer. Department of Health: London, UK.
29. Expert Advisory Group on Cancer (1995) A Policy Framework for Commissioning Cancer Services. Department of Health: London, UK.
30. Flitcroft KL, Salkeld GP, Gillespie JA, Trevena LJ, Irwig LM (2010) Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice? Med J Aust 193(1): 37-42.
31. Groene O, Chadwick G, Riley S, Hardwick RH, Crosby T, Greenaway K, Allum W, Cromwell DA (2014) Re-organisation of oesophago-gastric cancer services in England and Wales: a follow-up assessment of progress and remaining challenges. BMC Res Notes 7: 24.
32. Guren MG, Kørner H, Pfeffer F, Myklebust TÅ, Eriksen MT, Edna TH, Larsen SG, Knudsen KO, Nesbakken A, Wasmuth HH, Vonen B, Hofsli E, Færden AE, Brændengen M, Dahl O, Steigen SE, Johansen MJ, Lindsetmo RO, Drolsum A, Tollåli G, Dørum LM, Møller B, Wibe A (2015) Nationwide improvement of rectal cancer treatment outcomes in Norway, 1993-2010. Acta Oncol; e-pub ahead of print 30 April 2015; doi:10.3109/0284186X.2015.1034876.
33. Haasbeek CJ, Palma D, Visser O, Lagerwaard FJ, Slotman B, Senan S (2012) Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol 23(10): 2743-2747.
34. Hannan EL, Radzyner M, Rubin D, Dougherty J, Brennan MF (2002) The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 131(1): 6-15.
35. Hansen MH, Kjaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B, Norwegian Rectal Cancer Group (2007) Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 94(1): 113-118.
36. Health and Social Care Information Centre (2012) National Lung Cancer Audit Annual Report 2012: Report for the Audit Period 2011. Health and Social Care Information Centre: Leeds, UK.
37. Health and Social Care Information Centre (2014) National Lung Cancer Audit Annual Report 2014: Report for the Audit Period 2013. Health and Social Care Information Centre: Leeds, UK.
38. Hegney D, Pearce S, Rogers-Clark C, Martin-McDonald K, Buikstra E (2005) Close, but still too far. The experience of Australian people with cancer commuting from a regional to a capital city for radiotherapy treatment. Eur J Cancer Care (Engl) 14(1): 75-82.
39. House of Commons Committee of Public Accounts (2006) The NHS Cancer Plan: A Progress Report. House of Commons Stationery Office: London, UK.
40. House of Commons Committee of Public Accounts (2011) Delivering the Cancer Reform Strategy. HC667, Session 2010. The Stationery Office: London, UK.
41. Hsu C-C, Sandford BA (2007) The Delphi technique: making sense of consensus. Prac Assess Res Eval 12(10). Available at http://pareonline.net/ pdf/v12n10.pdf.
42. Jensen LS, Bendixen A, Kehlet H (2007) Organisation and early outcomes of major upper gastrointestinal cancer surgery in Denmark 1996-2004. Scand J Surg 96(1): 41-45.
43. Jensen LS, Nielsen H, Mortensen PB, Pilegaard HK, Johnsen SP (2010) Enforcing centralization for gastric cancer in Denmark. Eur J Surg Oncol 36(Suppl 1): S50-S54.
44. Jeppesen SS, Schytte T, Jensen HR, Brink C, Hansen O (2013) Stereotactic body radiation therapy versus conventional radiation therapy in patients with early stage non-small cell lung cancer: an updated retrospective study on local failure and survival rates. Acta Oncol 52(7): 1552-1558.
45. Jung B, Påhlman L, Johansson R, Nilsson E (2009) Rectal cancer treatment and outcome in the elderly: an audit based on the Swedish Rectal Cancer Registry 1995-2004. BMC Cancer 9: 68.
46. Khakwani A, Rich AL, Powell HA, Tata LJ, Stanley RA, Baldwin DR, Duffy JP, Hubbard RB (2013a) Lung cancer survival in England: trends in non-small-cell lung cancer survival over the duration of the National Lung Cancer Audit. Br J Cancer 109(8): 2058-2065.
47. Khakwani A, Rich AL, Tata LJ, Powell HA, Stanley RA, Baldwin DR, Hubbard RB (2013b) The pathological confirmation rate of lung cancer in England using the NLCA database. Lung Cancer 79(2): 125-131.
48. Kodeda K, Nathanaelsson L, Jung B, Olsson H, Jestin P, Sjövall A, Glimelius B, Påhlman L, Syk I (2013) Population-based data from the Swedish Colon Cancer Registry. Br J Surg 100(8): 1100-1107.
49. Lax I, Blomgren H, Naslund I, Svanstrom R (1994) Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33(6): 677-683.
50. Louie AV, Rodrigues GB, Palma DA, Senan S (2014) Measuring the population impact of introducing stereotactic ablative radiotherapy for stage I non-small cell lung cancer in Canada. Oncologist 19(8): 880-885.
51. Luengo-Fernandez R, Leal J, Gray A, Sullivan R (2013) Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 14(12): 1165-1174.
52. Lykke J, Roikjær O, Jess P (2013) The majority of surgical departments adhere to national Danish guidelines for surveillance after colorectal cancer surgery. Dan Med J 60(7): A4664.
53. Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, Gjerstorff ML, Hatcher J, Borge Johannesen T, McGahan CE, Meechan D, Middleton R, Tracey E, Turner D, Richards MA, Rachet B, ICBP Module 1 Working Group (2012) Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol 127: 75-82.
54. Maringe C, Walters S, Rachet B, Butler J, Fields T, Finan PJ, Maxwell R, Nedrebø B, Påhlman L, Sjövall A, Spigelman A, Engholm G, Gavin A, Gjerstorff ML, Hatcher J, Borge Johannesen T, Morris EJ, McGahan CE, Tracey E, Turner D, Richards MA, Coleman MP, ICBP Module 1 Working Group (2013) Stage at diagnosis and colorectal cancer survival in six highincome countries: a population-based study of patients diagnosed during 2000-7. Acta Oncol 52: 919-932.
55. Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B (2005) Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 92(2): 225-229.
56. McCulloch P, Ward J, Tekkis PP, Ascot Group of Surgeons, British Oesophago-Gastric Cancer Group (2003) Mortality and morbidity in gastro-oesophageal cancer surgery: initial results of ASCOT multicentre prospective cohort study. BMJ 327(7425): 1192-1197.
57. Meyer HJ (2005) The influence of case load and the extent of resection on the quality of treatment outcome in gastric cancer. Eur J Surg Oncol 31(6): 595-604.
58. Morris EJ, Taylor EF, Thomas JD, Quirke P, Finan PJ, Coleman MP, Rachet B, Forman D (2011) Thirty-day postoperative mortality after colorectal cancer surgery in England. Gut 60(6): 806-813.
59. National Audit Office (2015) Progress in Improving Cancer Services and Outcomes in England. National Audit Office: London, UK.
60. National Institute for Health and Clinical Excellence (NICE) (2011) Lung cancer: The Diagnosis and Treatment of Lung Cancer. NICE clinical guideline 121. NICE: London, UK.
61. NHS England (2015) Waiting Times for Suspected and Diagnosed Cancer Patients: 2014-15 Annual Report. Available at http://www.england.nhs.uk/ statistics/wp-content/uploads/sites/2/2015/05/CancerWaitingTimes AnnualReport-201415-Final.pdf (accessed 18 June 2015).
62. Norwegian Official Reports No. 20: 1997 (1997) Care and Knowledge! The Norwegian Cancer Plan - English Summary. Ministry of Health and Care Services: Oslo, Norway.
63. Olesen F, Hansen RP, Vedsted P (2009) Delay in diagnosis: the experience in Denmark. Br J Cancer 101(S2): S5-S8.
64. Ottesen B, Iversen MG, Kehlet H (2009) Surgical treatment for ovarian cancer in Denmark 2004-2007. Ugeskr Laeger 171(4): 217-220.
65. Page RD, McShane J, Kinsman R on behalf of the Society for Cardiothoracic Surgery in Great Britain & Ireland (2011) Second National Thoracic Surgery Activity and Outcomes Report 2011. Dendrite Clinical Systems Ltd: Henley-on-Thames, Report no. 978-0-9568154-1-5.
66. Påhlman L, Bohe M, Cedermark B, Dahlberg M, Lindmark G, Sjodahl R, Ojerskog B, Damber L, Johansson R (2007) The Swedish rectal cancer registry. Br J Surg 94(10): 1285-1292.
67. Pohar Perme M, Stare J, Estève J (2012) On Estimation in Relative Survival. Biometrics 68(1): 113-120.
68. Probst HB, Hussain ZB, Andersen O (2012) Cancer patient pathways in Denmark as a joint effort between bureaucrats, health professionals and politicians - A national Danish project. Health Policy 105(1): 65-70.
69. Rachet B, Maringe C, Nur U, Quaresma M, Shah A, Woods LM, Ellis L, Walters S, Forman D, Steward J, Coleman MP (2009) Population-based cancer survival trends in England and Wales up to 2007: an assessment of the NHS cancer plan for England. Lancet Oncol 10(4): 351-369.
70. Regionalt Cancercentrum Norr (2014) Rektalcancer Nationell kvalitetsrapport för diagnosår 2013 från Svenska Kolorektalcancerregistret. Regionalt cancercentrum, Norr: Umeå, Sweden.
71. Regionalt Cancercentrum Uppsala Örebro (2012) Lungcancer i Sverige Nationellt register för lungcancer Regionala jämförelser 2002-2010. Regionalt Cancer Centrum, Uppsala Örebror: Uppsala, Sweden.
72. Riaz SP, Linklater KM, Page R, Peake MD, Møller H, Lüchtenborg M (2012) Recent trends in resection rates among non-small cell lung cancer patients in England. Thorax 67(9): 811-814.
73. Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, Hubbard RB (2011a) How do patient and hospital features influence outcomes in small-cell lung cancer in England? Br J Cancer 105(6): 746-752.
74. Rich AL, Tata LJ, Free CM, Stanley RA, Peake MD, Baldwin DR, Hubbard RB (2011b) Inequalities in outcomes for non-small cell lung cancer: the influence of clinical characteristics and features of the local lung cancer service. Thorax 66(12): 1078-1084.
75. Rich AL, Tata LJ, Stanley RA, Free CM, Peake MD, Baldwin DR, Hubbard RB (2011c) Lung cancer in England: information from the National Lung Cancer Audit (LUCADA). Lung Cancer 72(1): 16-22.
76. Richards MA (2009) The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 101(Suppl 2): S125-S129.
77. Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Abraira V, Roque IFM (2014) PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev 11: Cd009519.
78. Scott N, Hill J, Kelly S, Fearnhead N, Kuryba A, Walker K, van der Meulen J, Greenaway G, Meace C, Bunn E (2014) National Bowel Cancer Audit Report 2014. Health and Social Care Information Centre: Leeds, UK.
79. Scott N, Hill J, Smith J, Walker K, Kuryba A, van der Meulen J, Greenaway G, Yelland A, Meace C (2013) National Bowel Cancer Audit Annual Report 2013. Health and Social Care Information Centre: Leeds, UK. Society for Cardiothoracic Surgery in Great Britain and Ireland (undated) Provisional 2013-14 Thoracic Returns Data Released. Available at http://www.scts.org/professionals/audit-outcomes/thoracic.aspx (accessed 17 May 2015).
80. Starr LK, Osler M, Steding-Jessen M, Frederiksen BL, Jakobsen E, Østerlind K, Schüz J, Johansen C, Dalton SO (2013) Socioeconomic position and surgery for early-stage non-small-cell lung cancer: a population-based study in Denmark. Lung Cancer 79(3): 262-269.
81. Taylor A, Chadwick G, Groene O, Cromwell D, Hardwick R, Riley S, Crosby T, Greenaway K (2014) National Oesophago-Gastric Cancer Audit Progress Report 2014. The Royal College of Surgeons of England: London, UK.
82. The NHS Information Centre (2006) National Lung Cancer Audit: Report for the Audit Period 2005. NHS IC: Leeds, UK.
83. Tracey E, Hacker NF, Young J, Armstrong BK (2014) Effects of access to and treatment in specialist facilities on survival from epithelial ovarian cancer in Australian women: a data linkage study. Int J Gynecol Cancer 24(7): 1232-1240.
84. Walters S, Maringe C, Coleman MP, Peake MD, Butler J, Young N, Bergström S, Hanna L, Jakobsen E, Kölbeck K, Sundstrøm S, Engholm G, Gavin A, Gjerstorff ML, Hatcher J, Børge Johannesen T, Linklater KM, McGahan CE, Steward J, Tracey E, Turner D, Richards MA, Rachet B, ICBP Module 1 Working Group (2013) Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom: a population-based study, 2004-2007. Thorax 68: 551-564.
85. Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, Langmark F, Myrvold HE, Søreide O, Norwegian Rectal Cancer Group (2002) A national strategic change in treatment policy for rectal cancer-implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45(7): 857-866.
86. Zavoral M, Suchanek S, Zavada F, Dusek L, Muzik J, Seifert B, Fric P (2009) Colorectal cancer screening in Europe. World J Gastroenterol 15(47): 5907-5915.